These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9083932)

  • 1. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.
    André S; Schatz O; Bogner JR; Zeichhardt H; Stöffler-Meilicke M; Jahn HU; Ullrich R; Sonntag AK; Kehm R; Haas J
    J Mol Med (Berl); 1997 Feb; 75(2):145-52. PubMed ID: 9083932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
    Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
    J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma.
    Katano H; Sata T; Suda T; Nakamura T; Tachikawa N; Nishizumi H; Sakurada S; Hayashi Y; Koike M; Iwamoto A; Kurata T; Mori S
    J Med Virol; 1999 Nov; 59(3):346-55. PubMed ID: 10502268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
    Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
    AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
    Davis DA; Humphrey RW; Newcomb FM; O'Brien TR; Goedert JJ; Straus SE; Yarchoan R
    J Infect Dis; 1997 May; 175(5):1071-9. PubMed ID: 9129068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay.
    Chatlynne LG; Lapps W; Handy M; Huang YQ; Masood R; Hamilton AS; Said JW; Koeffler HP; Kaplan MH; Friedman-Kien A; Gill PS; Whitman JE; Ablashi DV
    Blood; 1998 Jul; 92(1):53-8. PubMed ID: 9639499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients.
    Gayà A; Esteve A; Casabona J; McCarthy JJ; Martorell J; Schulz TF; Whitby D;
    AIDS; 2004 Jan; 18(2):199-204. PubMed ID: 15075536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma.
    Cattani P; Capuano M; Cerimele F; La Parola IL; Santangelo R; Masini C; Cerimele D; Fadda G
    J Clin Microbiol; 1999 Apr; 37(4):1150-3. PubMed ID: 10074540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction.
    Bobroski L; Bagasra AU; Patel D; Saikumari P; Memoli M; Abbey MV; Wood C; Sosa C; Bagasra O
    J Reprod Immunol; 1998 Dec; 41(1-2):149-60. PubMed ID: 10213307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of BC-3 and BCP-1 cell lines in immunofluorescence assay to detect HHV-8 antibodies in Kaposi's sarcoma, multiple myeloma and other groups.
    Couty JP; Ranger-Rogez S; Venot C; Jaccard A; Rogez JP; Weinbreck P; Bordessoule D; Denis F
    J Clin Virol; 1999 May; 12(3):221-31. PubMed ID: 10382819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
    Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
    Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America.
    Fouchard N; Lacoste V; Couppie P; Develoux M; Mauclere P; Michel P; Herve V; Pradinaud R; Bestetti G; Huerre M; Tekaia F; de Thé G; Gessain A
    Int J Cancer; 2000 Jan; 85(2):166-70. PubMed ID: 10629072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.
    Melbye M; Cook PM; Hjalgrim H; Begtrup K; Simpson GR; Biggar RJ; Ebbesen P; Schulz TF
    Int J Cancer; 1998 Aug; 77(4):543-8. PubMed ID: 9679756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus-8 (HHV-8) antibodies in women from São Paulo, Brazil. Association with behavioral factors and Kaposi's sarcoma.
    Caterino-De-Araujo A; de los Santos-Fortuna E; Carbone PH; Cibella SE; Moreira AA
    Braz J Infect Dis; 2003 Dec; 7(6):395-401. PubMed ID: 14636479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.
    Angeloni A; Heston L; Uccini S; Sirianni MC; Cottoni F; Masala MV; Cerimele D; Lin SF; Sun R; Rigsby M; Faggioni A; Miller G
    J Infect Dis; 1998 Jun; 177(6):1715-8. PubMed ID: 9607855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.